|
ИСТИНА |
Войти в систему Регистрация |
ИПМех РАН |
||
Discovery of a novel role of tumor suppressor PDCD4 in stimulation of translation terminationстатья Исследовательская статья
Информация о цитировании статьи получена из
Web of Science,
Scopus
Статья опубликована в журнале из списка Web of Science и/или Scopus
Дата последнего поиска статьи во внешних источниках: 22 декабря 2021 г.
- Авторы: Shuvalova Ekaterina, Egorova Tatyana, Ivanov Alexander, Shuvalov Alexey, Biziaev Nikita, Mukba Sabina, Pustogarov Nikolay, Terenin Ilya, Alkalaeva Elena
- Журнал: Journal of Biological Chemistry
- Том: 297
- Номер: 5
- Год издания: 2021
- Издательство: American Society for Biochemistry and Molecular Biology Inc.
- Местоположение издательства: United States
- Номер статьи: 101269
- DOI: 10.1016/j.jbc.2021.101269
- Аннотация: Programmed cell death 4 (PDCD4) regulates many vital cell processes, although is classified as a tumor suppressor because it inhibits neoplastic transformation and tumor growth. For example, PCDC4 has been implicated in the regulation of transcription and mRNA translation. PDCD4 is known to inhibit translation initiation by binding to eukaryotic initiation factor 4A, and elongation of oncogenic c- and A-myb mRNAs. Additionally, PDCD4 has been shown to interact with poly(A)-binding protein (PABP), which affects translation termination, although the significance of this interaction is not fully understood. Considering the interaction between PABP and PDCD4, we hypothesized that PDCD4 may also be involved in translation termination. Using in vitro translation systems, we revealed that PDCD4 directly stimulates translation termination. PDCD4 stimulates peptidyl-tRNA hydrolysis induced by a complex of eukaryotic release factors, eRF1-eRF3. Moreover, in combination with the PABP, which also stimulates peptide release, PDCD4 activity in translation termination increases. PDCD4 regulate translation termination by stimulating the binding of release factors to the ribosome, increasing the GTPase activity of eRF3 and dissociating eRF3 from the post-termination complex. Using a toe-printing assay, we determined the first stage at which PDCD4 functions – binding of release factors to the A-site of the ribosome. However, preventing binding of eRF3 with PABP, PDCD4 suppresses subsequent rounds of translation termination. Based on these data, we assumed that human PDCD4 controls protein synthesis during translation termination. The described mechanism of the activity of PDCD4 in translation termination provides a new insight into its functioning during suppression of protein biosynthesis.
- Добавил в систему: Теренин Илья Михайлович